Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial

BACKGROUND: The newly discovered coronavirus has turned into coronavirus disease 2019 (COVID-19) pandemic and it rages at an unprecedented rate. Considering the findings of previous studies on the use of Intravenous Immunoglobulin (IVIg) for treating severe H(1)N(1) infection and the satisfying resu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int Immunopharmacol
Main Authors: Tabarsi, Payam, Barati, Saghar, Jamaati, Hamidreza, Haseli, Sara, Marjani, Majid, Moniri, Afshin, Abtahian, Zahra, Dastan, Alireza, Yousefian, Sahar, Eskandari, Raha, Saffaei, Ali, Monjazebi, Fatemeh, Vahedi, Abdolbaset, Dastan, Farzaneh
Formato: Artigo
Idioma:Inglês
Publicado em: Published by Elsevier B.V. 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7665876/
https://ncbi.nlm.nih.gov/pubmed/33214093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.intimp.2020.107205
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados